
Over deze podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
207 afleveringen · health
On The Pen GLP-1 News
Over deze podcast
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Nieuwste afleveringGLP-1 for 6 Year Olds? Here’s What the Trial Actually Found
Recente afleveringen
- We’re Solving Obesity. Now Who Pays for It?2 sep · 25 min
- GLP-1 Coverage Is COLLAPSING in 202726 aug · 35 min
- $50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”18 aug · 45 min
- 200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study12 aug · 31 min
- Eli Lilly Earnings Call Recap: Retatrutide News7 aug · 1 u 00 min
- Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.4 aug · 19 min
- Retatrutide Biologic Battle: The Story Gets Bigger28 jul · 21 min
- GLP-1 Showdown: Inside The High Stakes War over Patients22 jul · 27 min
- Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know14 jul · 32 min
- Compound GLP-1 Poll STUNS THE INTERNET!8 jul · 16 min